Salt Lake City, UT, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announces the signing of a Joint Development Agreement (JDA) with NED Medical Inc., an innovative developer of oncology embolization therapy technologies. This collaboration aims to accelerate the development of advanced ceramic-based microspheres, ...

Seasoned Healthcare Executive to Lead Strategic Growth Initiatives Salt Lake City, UT, Nov. 19, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, is pleased to announce the appointment of Gregg R. Honigblum as Chief Strategy Officer (CSO). In this role, Mr. Honigblum will oversee driving corporate strategy to support SINTX’s ...

Salt Lake City, UT , Nov. 18, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, today announced that its Board of Directors has authorized a stock repurchase program to buy back up to $500,000 of the company’s outstanding common stock over the next several quarters which equates to about 20% of total outstanding shares. The r ...

Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announced today a positive update on its recent strategic initiatives and financial performance, showcasing the Company’s commitment to realigning its resources and achieving long-term growth. In line with its ongoing evaluation of a change in stra ...

营收情况 - 2024年第三季度产品营收较2023年同期增加0.2百万美元涨幅118%[108] - 2024年第三季度授予和合同营收较2023年同期减少0.1百万美元降幅15%[108] - 2024年前九个月产品营收较2023年同期增加0.4百万美元涨幅64%[109] - 2024年前九个月授予和合同营收较2023年同期增加0.2百万美元涨幅19%[109] - 营收增长主要源于盐湖城运营中的氮化硅航空航天部件新订单以及政府拨款和合同还有马里兰运营中的商业和政府合同收入[110] 费用情况 - 2024年第三季度研发费用较2023年同期减少1.7百万美元降幅68%[112] - 2024年前九个月研发费用较2023年同期减少2.4百万美元降幅35%[112] - 2024年第三季度一般和管理费用较2023年同期减少0.2百万美元降幅19%[113] - 2024年前九个月一般和管理费用较2023年同期减少0.3百万美元降幅10%[114] - 2024年第三季度销售和营销费用较2023年同期减少0.2百万美元降幅66%[115] - 2024年前9个月装甲退出成本增加450万美元，增幅100%[117] - 2024年第三季度裁员费用增加40万美元，增幅100%[117] - 2024年前9个月赠款和合同费用增加10万美元，增幅13%[119] 其他收支情况 - 2024年第三季度其他收入减少20万美元，降幅60%[119] - 2024年前9个月净亏损930万美元，2023年为590万美元[121] - 2024年前9个月经营活动使用现金750万美元，2023年为1100万美元[121] 公开发行收益情况 - 2024年2月10日公开发行收益约1200万美元[123] - 2024年2月2日公开发行收益400万美元[124] - 2024年3月26日公开发行收益约130万美元[125] - 2024年4月5日公开发行收益约150万美元[126] 贷款偿还情况 - 2021年7月20日公司获取35万美元商业贷款已在2023年第一季度全额还清[143] - 2022年9月30日个人贷款总额约35万美元已在2024年第三季度全额还清[144] - 富国银行信贷额度截至2024年9月30日无未偿余额且账户已关闭[145] 保险保费融资情况 - 2024年3月保险保费融资安排预付款4万美元融资约23.9万美元年利率8.510% 9月30日未偿余额7万美元[145] - 2024年6月保险保费融资安排预付款2.6万美元融资约11.7万美元年利率8.75% 9月30日未偿余额6.4万美元[146] 会计相关情况 - 公司无表外安排[147] - 截至2024年9月30日九个月内重大会计政策无重大变更[148] - 新会计公告未采用情况参考相关文件[149] 市场风险披露情况 - 市场风险的定量和定性披露不适用[149]

Salt Lake City, Utah, Oct. 01, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company") an advanced materials company specializing in ceramics for biomedical, aerospace, and industrial applications, is pleased to announce two key executive promotions. Effective immediately Ryan Bock, PhD has been promoted to Chief Technology Officer (CTO) of SINTX Technologies, Inc., and Ann Kutsch has been promoted to President of SINTX Technology Assessment and Transfer (SINTX TA&T), a s ...

收入与成本 - 公司产品收入和政府合同收入均有增长，分别增长61%和76%[138,139] - 成本上升导致毛利率有所下降，但仍保持较高水平[141,142] 费用管理 - 研发费用下降主要由于专利费用和工具成本的减少[143,144] - 管理费用下降主要由于员工薪酬和招聘费用的减少[145,146] - 销售费用下降主要由于咨询费用的减少[147,148] - 政府合同费用随收入增长而相应增加[149,150] 其他收益与收入 - 其他收益下降主要由于衍生工具公允价值变动的减少[151] - 其他收入同比下降34%,主要是由于衍生负债公允价值变动减少170万美元,但被衍生负债相关成本增加20万美元所抵消[152] 持续经营能力 - 公司持续亏损且经营活动现金流为负,截至2024年6月30日累计亏损2.738亿美元,存在持续经营能力的不确定性[154] - 公司正积极寻求增加资本的机会,但无法保证能以有利条件获得融资[156] 融资活动 - 2024年2月公司完成了约400万美元的公开发行,发行包括普通股、认股权证等[160] - 2023年2月公司完成了约1200万美元的公开发行,其中约670万美元分配至衍生负债[161] - 2022年10月公司完成了约470万美元的优先股和认股权证的权益发行[162] 现金流 - 2024年上半年经营活动现金流出减少310万美元,主要是由于净亏损减少120万美元以及营运资金变动[166] - 2024年上半年投资活动现金流出减少16万美元,主要是由于收回应收款增加30万美元,但购置固定资产增加20万美元[167] - 2024年上半年筹资活动现金流入减少520万美元,主要是由于发行衍生负债所得款项减少330万美元,发行普通股所得款项减少170万美元[168]

Salt Lake City, Utah., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company") today announced that its Board of Directors has appointed Eric K. Olson to succeed B. Sonny Bal, MD as the Company's Chief Executive Officer and President. Mr. Olson's appointment follows the Company's recent announcement that Dr. Bal was retiring from his position as Chief Executive Officer and President effective upon the appointment of a new chief executive officer and president by t ...

Salt Lake City, Utah., June 18, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company") today announced that its Board of Directors has initiated a process to explore potential strategic options for the Company. SINTX has multiple business lines focused on technical materials, with manufacturing and R&D sites located in Salt Lake City and Millersville, MD. In addition to its FDA-approved silicon nitride ceramic spinal fusion devices, the Company has developed ceramic-poly ...

Salt Lake City, Utah., June 12, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (SINTX) (www.sintx.com) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, today announced that on June 11, 2024, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has evidenced compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Ru ...